Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, this silent shareholder certainly does not.
Up over a dollar in after hours.
It takes two to deal. JnJ may be very interested. Other. BP may be interested. IPIX has stated the intent to maximize value. Results for B-IP and B-OM are the second and third leg of the three legged stool that is the (start of the), B franchise.
"Why can't Leo do a deal?" "Why is small pharm X getting an offer while IPIX shareholders are left to suffer?" WahWah.
B could sell tomorrow. B could have been sold after ABSSSI ph2. If sold yesterday B would have been sold too low. Cash would have been left on the table.
IPIX should continue to shoulder the risk and accumulate data for multiple treatment paths. When the amassed data maximizes the potential of a deal, out right sale or license agreement, Leo will execute.
And on very healthy volume. A good day for BTX.
I agree. Leo said as much in the cc. IPIX has defined a high value for its drugs and for the company. IPIX has a fixed the price tag for those BP who have come shopping. Leo will assure value for shareholders. (”...I'm a shareholder too.")
Unlike hired gun CEOs brought into make a deal whose only criteria is achieving a price that pulls the cord on their golden parachute, empty suit CEOs whose dispassion permits selling out, Leo built IPIX, he can see what it will be worth 10 years on from today and will fight doggedly to get his price. Leo will make longs with vision and brass b#lls rich.
I have large, solid, cool in the hottest condition, brass babies and I'm holding IPIX until FU wealth is mine.
I have listened repeatedly, as recently as yesterday evening. Initially I attempted to listen via my iPad. This was on the afternoon of the cc and via iPad I was unable to play the audio.
I suspected there might be a technical issue using Safari and iOS so I accessed the links via PC. On my PC the cc audio can be accessed without issue.
Try PC. Try a different browser. It is worth the effort.
Note: I just attempted again on iPad. Unsuccessful. Use PC. Go to the library if necessary. The transcript has value but its inaccuracies ("l can talk about SP..." when in reality Leo said; "I can't..."), misidentification of speakers, callers, missing words (Oh wow.), and the transcript's failure to capture the enthusiasm of the speakers leave it wanting.
Good luck.
I strongly recommend listening to the cc as well as reading the transcript. The SA transcript in not fully accurate. In addition to misidentifying speakers the transcript fails to transmit the enthusiasm of LE and Dr. AB.
If you merely read the transcript you'll miss the "Oh Wow." moment.
BTW, count the CDA references, references related to multiple BP and reflecting discussions related to K, B and P.
Leo states, IPIX has set a high price for partnering and/or buy out and they have communicated the high price to BP.
Often repeated on the board; know what you own. IPIX knows.
I can't say but I can imagine...
An inter generational battle between a brash young talent from a sunny city of luxury and flash versus a working man's hero from a hardscrabble eastern city in decline, a man with a haircut you could set your watch to.
Parse his post. He has made no claim. Rather, he has cast aspirations. (Rinse and repeat. This post can be applied to many of his previous posts.)
Are you rounding up from the 320 million reported on their website or eluding to an unannounced stock sale?
Don't make the mistake, or lead others to make the mistake, that BK claims are being made out of ignorance. Misinformation is being used as a tool to frighten shareholders and in an effort to scare potential shareholders away.
Predictions of .60s, warnings of BK, cries of malfeasance and incompetence by the CTIX management team are narrative elements meant to achieve a desired result not honest observations and conclusions based on fundamentals and clinical trial results.
I thynk thats shud. (Stoopid line of questioning decerves stoopid ceries off replyes.)
Of course B-OM will be used to treat OM for all cancers. Beyond that, B-OM will be recognized as a preventative and prescribed for all undergoing radiation/chemo. It will be a given that the cost associated with a course of B-OM is insignificant versus the possibility of treatment-disrupting OM. The market for the first demonstrated preventative, one with no Adverse side effects, will be far greater than the projections built on potential Head and Neck cancer numbers. B-OM is a medically beneficial, breakthrough money maker. Slam dunk.
Interesting supposition. I've been reluctant to surrender to the enthusiasm related to the "hastily arranged" CC. Just because the public has only recently been informed does not mean Cellceutix hadn't planned this a while ago.
If my notes are accurate the November 2016 Conference Call was only announced 3 day in advance.
I'd like this to be a monumental event highlighted by stellar P and K updates (we've already had enough positive B news, let's not get greedy) and news of a shareholder-enriching partnership but...my hopes (Leo's hopes, Dr. B's hopes), don't influence clinical outcomes, corporate timetables and market sentiments.
I'm long. I'm optimistic. I'm not holding my breath for CC revelations.
Bias is real. Hope and desire can unduly influence interpretation. It's important to remain grounded and to be reminded to remain grounded.
Thanks.
GLTA longs.
Right in IEVM's wheelhouse.
Thanks for your perseverance.
A man of few...ah, no words.
Something is brewing.
Ah, a poster who rarely posts but posts rare wisdom. Thanks kfc.
They sold the VET solution. Rights to use the product in veterinary treatments. Oil industry opportunity is untouched. Food service use case untouched.
Cash to continue building from an indication they would not have gotten around to pursuing for years.
The longer CTIX bears the burden of risk, the further it can progress without dilution, the greater the reward to shareholders.
I love every minute of this adventure.
I can carry my share of this burden.
If it becomes too much for you...sell.
I'll buy your discounted treasure.
I'll carry my load and yours too.
And if I'm crushed under the weight of my ambitions, I'll have failed falling forward.
Better then drowning in tears, beating my breast and suffering humiliation day after day on iHub.
Cowards die a thousand deaths.
This bull lives!
One further consideration. 400000 OM cases reported annually. Not all receiving treatment experience OM. Some do, some do not. Who will suffer OM, whose treatment will be in jeopardy? If the cost is reasonable, as a precaution, B-OM will be prescribed for ALL potential suffers. How large is that market?
We're going to need a bigger boat.
I'm enjoying a beautiful rainbow...before it disappears.
Wanted: Partner
Me: independent, young and very attractive
No inflammation
Smooth clear skin
Absolutely no wild p53s
Some money challenges. But hey, that's to your advantage.
If I had money I'd maintain my independence, at least
Through another phase.
You: Wealthy
Worldly
Wise (you must be if you're interested in me)
Take a chance. I have many outstanding dependents. Sure they fight among themselves over my behavior and outspoken proclamations but really they're very sweet. (Except for the short ones)
Contact me soon. Lots of suitors calling.
I also like;
Bridging toxicology studies ARE NOW UNDERWAY to enable this transition to oral dosing of patients.
Thank you Karin. Your clarification was thoughtful and beneficial.
10,000 additional at .93...thanks AF.
The co is under attack as the shorts know their time is running out. Squeeze!
“To date, the trial has exceeded our expectations on all fronts..."
And based on the enthusiasm of the press release, treatment has exceeded expectations on a few rears.
GLTA long CTIX.
I'm going to go out on a limb here. I believe that Dr. B misspoke or poorly expressed his thought.
I was out to visit the Shelton facility last Friday. Big progress since my last visit. The staff is very enthusiastic and working well as a team as they accelerate multiple initiatives.
The visit was encouraging. GLTA.
Thank you for the time and thought you put into this and many other posts.
The sales cycle, at this early stage, involves servicing test wells, demonstrating efficacy and ROI for potential clients. As market share increases the test wells in question will be the wells of a competitor down the road. A strong reputation will replace testing and the sales cycle will shorten dramatically.
I fully agree.
Carnegie Hall has limited performance space. Carnegie Hall has a reputation and performance standards to preserve. Granted, labs may have a lower bar and may be more mercenary, more apt to make decisions based on financial opportunity. I think it's fair to assume Universities fall somewhere between Carnegie Hall and a profit motivated lab. In the case of UW I bet their decision making criteria is closer to the Carnegie Hall end of the spectrum.
The oil patch will generate significant revenue. That should have a good impact on SP in your timeframe. I'm waiting for business lines in food service and medical facility clean up to mature and add to overall SP value.
I have a crock pot full of IEVM shares. When I return to feast in 3 years time it will be delicious.